Ocean Accounts Payable from 2010 to 2025

OCEAW Stock   0.04  0.01  38.00%   
Ocean Biomedical Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable is likely to outpace its year average in 2025. Accounts Payable is the amount Ocean Biomedical owes to suppliers or vendors for products or services received but not yet paid for. It represents Ocean Biomedical's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2010-12-31
Previous Quarter
1.1 M
Current Value
1.1 M
Quarterly Volatility
417.5 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Ocean Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ocean Biomedical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.8 M, Selling General Administrative of 10.4 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Ptb Ratio of 3.44 or Days Sales Outstanding of 0.0. Ocean financial statements analysis is a perfect complement when working with Ocean Biomedical Valuation or Volatility modules.
  
Check out the analysis of Ocean Biomedical Correlation against competitors.
For more information on how to buy Ocean Stock please use our How to Invest in Ocean Biomedical guide.

Latest Ocean Biomedical's Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Ocean Biomedical over the last few years. An accounting item on the balance sheet that represents Ocean Biomedical obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Ocean Biomedical are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Ocean Biomedical's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ocean Biomedical's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Ocean Accounts Payable Regression Statistics

Arithmetic Mean221,551
Geometric Mean0.00
Coefficient Of Variation188.46
Mean Deviation321,396
Median0.00
Standard Deviation417,539
Sample Variance174.3B
Range1.1M
R-Value0.75
Mean Square Error82.6B
R-Squared0.56
Significance0.0009
Slope65,500
Total Sum of Squares2.6T

Ocean Accounts Payable History

20251.1 M
20241.1 M
2023933 K
2022324.8 K
202134.4 K
202053 K

About Ocean Biomedical Financial Statements

Ocean Biomedical investors use historical fundamental indicators, such as Ocean Biomedical's Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Ocean Biomedical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable1.1 M1.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Ocean Stock Analysis

When running Ocean Biomedical's price analysis, check to measure Ocean Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocean Biomedical is operating at the current time. Most of Ocean Biomedical's value examination focuses on studying past and present price action to predict the probability of Ocean Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocean Biomedical's price. Additionally, you may evaluate how the addition of Ocean Biomedical to your portfolios can decrease your overall portfolio volatility.